Estonia-based Better Medicine raises nearly $7 million to expand its radiology AI solution and enter the U.S. market.
Key Details
- 1Better Medicine is an AI startup focused on radiology, founded in 2020 in Estonia.
- 2The company raised an additional $1.2 million, bringing total funding close to $7 million.
- 3Its flagship product, BMVision Kidney, detects malignant lesions from CT scans.
- 4Better Medicine currently operates in six countries and aims to expand to the U.S.
- 5The new funding will support further European growth and preparations for U.S. market entry.
Why It Matters
Better Medicine's growth and international expansion reflect ongoing investor confidence in radiology AI. Tools that integrate into radiologist workflows and target specific organs, such as the kidney, could enhance cancer detection and address radiologist shortages globally.
Source
Radiology Business
Related News
•Radiology Business
AI-Powered Tool Streamlines CT Scan Prioritization in Emergency Departments
An AI-based CT queue system significantly reduces wait times for ED patients by prioritizing scans likely to reveal critical findings.
•Radiology Business
CARPL.ai Raises $10M to Expand Radiology AI Marketplace
CARPL.ai secured $10M in Series A funding to expand its global radiology AI marketplace.
•AuntMinnie
Radiologists Struggle to Spot AI-Generated Radiology Images
Radiologists correctly identify AI-generated images 75% of the time, with CT and MRI images being particularly challenging to spot.